B-D-Galactose

B-D-Galactose

SCHEMBL360345

OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O.Oc1cccc2cccnc12

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 1/20 0.57
CHRM1 P11229 1/20 0.57
TSHR P16473 1/20 0.57
COMT P21964 1/20 0.57
ADRA1A P35348 1/20 0.57
METAP2 P50579 1/20 0.57
METAP1 P53582 1/20 0.57
HDAC8 Q9BY41 1/20 0.57
ALOX12 P18054 2/20 0.50
KDM4E B2RXH2 2/20 0.50
ALDH1A1 P00352 2/20 0.45
LMNA P02545 1/20 0.45
SLC5A2 P31639 6/20 0.42
SLC28A3 Q9HAS3 2/20 0.41
MAPT P10636 2/20 0.39
MEN1 O00255 1/20 0.39
NSD2 O96028 1/20 0.39
BLM P54132 1/20 0.39
KMT2A Q03164 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dextrose SCHEMBL2777597 1.00 MMP2 (0.57) MMP2CHRM1TSHRCOMTADRA1A
Beta-D-Glucose SCHEMBL360644 1.00 MMP2 (0.57) MMP2CHRM1TSHRCOMTADRA1A
Glucuronate SCHEMBL10769722 0.79 HDAC8 (0.54) MMP2CHRM1TSHRCOMTADRA1A
Glucuronate SCHEMBL4908209 0.79 HDAC8 (0.54) MMP2CHRM1TSHRCOMTADRA1A
Oxyquinoline SCHEMBL69253 0.77 TSHR (0.95) MMP2CHRM1TSHRCOMTADRA1A
Oxyquinoline SCHEMBL29450503 0.77 TSHR (0.95) MMP2CHRM1TSHRCOMTADRA1A
Oxyquinoline SCHEMBL11034114 0.77 TSHR (0.95) MMP2CHRM1TSHRCOMTADRA1A
Oxyquinoline SCHEMBL230604 0.77 TSHR (0.95) MMP2CHRM1TSHRCOMTADRA1A
Oxyquinoline SCHEMBL2235713 0.77 TSHR (0.95) MMP2CHRM1TSHRCOMTADRA1A
Oxyquinoline SCHEMBL29441270 0.77 TSHR (0.95) MMP2CHRM1TSHRCOMTADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2192408-A1 Agents and methods for spectrometric analysis Morpho Detection, Inc. (US) 2010-06-02 EP claimed
US-20100129795-A1 AGENTS AND METHODS FOR SPECTROMETRIC ANALYSIS GENERAL ELECTRIC COMPANY (US) 2010-05-27 US claimed
US-20100129787-A1 AGENTS AND METHODS FOR SPECTROMETRIC ANALYSIS GENERAL ELECTRIC COMPANY (US) 2010-05-27 US claimed
US-20100129785-A1 AGENTS AND METHODS FOR SPECTROMETRIC ANALYSIS GENERAL ELECTRIC COMPANY (US) 2010-05-27 US claimed
US-20100129786-A1 AGENTS AND METHODS FOR SPECTROMETRIC ANALYSIS GENERAL ELECTRIC COMPANY (US) 2010-05-27 US claimed
US-20240148918-A1 Loading of Alginate Microspheres BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2024-05-09 US disclosed
EP-2453927-B1 LOADING TECHNIQUE FOR PREPARING RADIONUCLIDE AND IONOPHORE CONTAINING LIPOSOMES IN WHICH THE IONOPHORE IS 2-HYDROXYQUIONOLINE (CARBOSTYRIL) OR STRUCTURALLY RELATED 2-HYDROXYQUINOLINES UNIV DENMARK TECH DTU (DK) 2019-05-15 EP disclosed
US-20160158392-A1 Entrapment of Radionuclides in Nanoparticle Compositions RIGSHOSPITALET (DK) 2016-06-09 US disclosed
US-9226984-B2 Entrapment of radionuclides in nanoparticle compositions Technical University of Denmark and Rigshospitalet (DK) 2016-01-05 US disclosed
US-20150202336-A1 Loading Technique for Preparing Radionuclide Containing Nanoparticles RIGSHOSPITALET (DK) 2015-07-23 US disclosed
US-8920775-B2 Loading technique for preparing radionuclide containing nanoparticles TECHNICAL UNIVERSITY OF DENMARK (DK) 2014-12-30 US disclosed
US-20140113327-A1 BIOCHEMICAL SENSOR FOR QUANTITATIVE SIMULTANEOUS MULTI-SPECIES BACTERIA DETECTION IN SITU Environmental Technology Solutiions LLC (US) 2014-04-24 US disclosed
EP-2453927-A1 LOADING TECHNIQUE FOR PREPARING RADIONUCLIDE AND IONOPHORE CONTAINING LIPOSOMES IN WHICH THE IONOPHORE IS 2-HYDROXYQUIONOLINE (CARBOSTYRIL) OR STRUCTURALLY RELATED 2-HYDROXYQUINOLINES Technical University of Denmark (DK) 2012-05-23 EP disclosed
WO-2012007567-A1 NANOPARTICLE-GUIDED RADIOTHERAPY TECHNICAL UNIVERSITY OF DENMARK (DK) 2012-01-19 WO disclosed
WO-2011006510-A1 LOADING TECHNIQUE FOR PREPARING RADIONUCLIDE AND IONOPHORE CONTAINING LIPOSOMES IN WHICH THE IONOPHORE IS 2-HYDROXYQUIONOLINE (CARBOSTYRIL) OR STRUCTURALLY RELATED 2-HYDROXYQUINOLINES TECHNICAL UNIVERSITY OF DENMARK (DK) 2011-01-20 WO disclosed
EP-2192408-A1 Agents and methods for spectrometric analysis Morpho Detection, Inc. (US) 2010-06-02 EP disclosed
US-20100129795-A1 AGENTS AND METHODS FOR SPECTROMETRIC ANALYSIS GENERAL ELECTRIC COMPANY (US) 2010-05-27 US disclosed
US-20100129787-A1 AGENTS AND METHODS FOR SPECTROMETRIC ANALYSIS GENERAL ELECTRIC COMPANY (US) 2010-05-27 US disclosed
US-20100129785-A1 AGENTS AND METHODS FOR SPECTROMETRIC ANALYSIS GENERAL ELECTRIC COMPANY (US) 2010-05-27 US disclosed
US-20100129786-A1 AGENTS AND METHODS FOR SPECTROMETRIC ANALYSIS GENERAL ELECTRIC COMPANY (US) 2010-05-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150202336-A1 Loading Technique for Preparing Radionuclide Containing Nanoparticles LIPG, NPC1L1, CD47 MMP2 2927/4885CHRM1 4737/4885TSHR 3606/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.